<DOC>
	<DOCNO>NCT01439776</DOCNO>
	<brief_summary>Standard therapy chronic hepatitis C virus ( HCV ) ( Peg/RBV ) combination therapy obtain sustain virologic response ( SVR ) 77 % naïve patient genotype 1-3 Studies rarely address issue improve host factor . The current study examine whether add vitamin D Peg/RBV , potent immunomodulator , could improve viral response ( SVR ) compare Peg/RBV .</brief_summary>
	<brief_title>Add Vitamin D With Standard Care Chronic Hepatitis C Patients</brief_title>
	<detailed_description>The work hypothesis Adding vitamin D conventional Peg/RBV therapy naïve , genotype 1-3 patient chronic HCV infection significantly improve RVR , EVR additionally .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Chronic genotype 13 HCV infection Treatment Naive Child B C HCC patient Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>chronic hepatitis C</keyword>
	<keyword>SVR</keyword>
	<keyword>Vit D</keyword>
	<keyword>Peginterferon alfa 2a</keyword>
	<keyword>Ribavirin</keyword>
</DOC>